GUGLIELMO, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 3.023
EU - Europa 1.533
AS - Asia 787
SA - Sud America 26
OC - Oceania 13
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.394
Nazione #
US - Stati Uniti d'America 2.994
CN - Cina 452
IT - Italia 422
DE - Germania 198
IE - Irlanda 186
SE - Svezia 130
AT - Austria 124
FR - Francia 104
SG - Singapore 95
GB - Regno Unito 89
FI - Finlandia 80
UA - Ucraina 74
PL - Polonia 60
IN - India 58
VN - Vietnam 45
KR - Corea 40
JP - Giappone 36
CA - Canada 24
TR - Turchia 17
BR - Brasile 16
BE - Belgio 14
RU - Federazione Russa 14
AU - Australia 9
CH - Svizzera 9
HK - Hong Kong 9
IQ - Iraq 8
IR - Iran 8
NL - Olanda 6
TW - Taiwan 6
ES - Italia 5
MX - Messico 5
CL - Cile 4
GR - Grecia 4
NZ - Nuova Zelanda 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AR - Argentina 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
ID - Indonesia 3
PT - Portogallo 3
TH - Thailandia 3
BQ - ???statistics.table.value.countryCode.BQ??? 2
EC - Ecuador 2
EU - Europa 2
SA - Arabia Saudita 2
SN - Senegal 2
CO - Colombia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MW - Malawi 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
Totale 5.394
Città #
Ann Arbor 389
Chandler 316
Fairfield 281
Beijing 234
Ashburn 230
Dublin 184
Houston 165
Torino 141
Woodbridge 134
Seattle 122
Vienna 122
Wilmington 107
Cambridge 99
Pisa 90
Villeurbanne 70
Jacksonville 68
Medford 63
Singapore 58
Dearborn 57
Warsaw 57
Nyköping 53
Princeton 52
Fremont 47
Redwood City 45
Dong Ket 24
San Diego 24
Shanghai 23
Shenyang 20
Boardman 18
Guangzhou 17
Hangzhou 16
Boston 15
Brussels 14
Nanjing 14
Naples 14
New York 13
Cardiff 12
Milan 12
Nottingham 12
Pune 11
Washington 11
Jinan 10
Munich 10
Ottawa 10
Phoenix 10
Tokyo 10
Turin 10
Helsinki 9
Buffalo 8
Norwalk 8
Nürnberg 8
Changsha 7
Fuzhou 7
Toronto 7
Upper Marlboro 7
Bari 6
Hefei 6
Kunming 6
Santa Clara 6
Silver Spring 6
Suzhou 6
Toledo 6
Donetsk 5
Hamburg 5
Leinì 5
London 5
Atlanta 4
Dallas 4
Florence 4
Goianesia Do Para 4
Hyderabad 4
Lansing 4
Los Angeles 4
Montecassiano 4
Nanchang 4
Nuremberg 4
Rochester 4
Rome 4
San Jose 4
Taipei 4
Berlin 3
Catanzaro 3
Chengdu 3
Fiorenzuola d'Arda 3
Gurgaon 3
Helensburgh 3
Istanbul 3
Memphis 3
Pesaro 3
Raritan 3
Siena 3
São Bernardo 3
São Paulo 3
Ulyanovsk 3
Voorhees Township 3
Xian 3
Absecon 2
Alessandria 2
Almendralejo 2
Amalfi 2
Totale 3.749
Nome #
New furoxan derivatives for the treatment of ocular hypertension 274
Doxorubicin-antioxidant multitarget drugs 253
A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity 226
Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients 196
Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein 172
Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis 168
New nitric oxide or hydrogen sulfide releasing aspirins 164
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity 160
Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria 159
Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues. 151
Anti-pseudomonas activity of 3-nitro-4-phenylfuroxan 146
Thermosensitive nanocomposite hydrogels for intravitreal delivery of cefuroxime 146
Light-Tunable Generation of Singlet Oxygen and Nitric Oxide with a Bichromophoric Molecular Hybrid: a Bimodal Approach to Killing Cancer Cells 142
Tandem Mass Spectrometry of Nitric Oxide and Hydrogen Sulfide Releasing Aspirins: A Hint into Activity Behavior 135
Direct introduction of cyano group on furoxan ring 135
gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension 134
A Potent and Selective P-gp Modulator for Altering Multidrug Resistance Due to Pump Overexpression 131
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells 129
Searching for new NO-donor aspirin-like molecules: furoxanylacyl derivatives of salicylic acid and related furazans 127
Synthesis and in vitro antimicrobial activities of new (cyano-NNO-azoxy)pyrazole derivatives 125
Synthesis and Biological Evaluation of N2-Substituted 2,4-Diamino-6-cyclohexylmethoxy-5-nitrosopyrimidines and Related 5-Cyano-NNO-azoxy Derivatives as Cyclin-Dependent Kinase 2 (CDK2) Inhibitors 121
Molecular dynamics simulations reveal the determinants of cyclin-dependent kinase 2 inhibition by 5-nitrosopyrimidine derivatives 117
Nitric Oxide Donor Doxorubicins Accumulate into Doxorubicin-Resistant Human Colon Cancer Cells Inducing Cytotoxicity 117
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 113
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni 112
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells 108
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro 103
Mitochondrial delivery of phenol substructure triggers mitochondrial depolarization and apoptosis of cancer cells 97
Leishmanicidal Activity of Novel Synthetic Furoxan and Benzofuroxan Derivatives 94
DNA-targeted NO release photoregulated by green light 90
Sistemi nanocompositi termosensibili per la somministrazione intravitreale di cefuroxima 89
Synthesis, physico-chemical characterization, andbiological activities of new carnosine derivatives stablein human serum as potential neuroprotective agents 88
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. 88
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 82
Praziquantel analogues containing NO-donor furoxans and related furazans as agents active against Schistosoma mansoni. 76
One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells 73
Hybrid praziquantel-oxadiazole oxides with activity against Schistosoma mansoni. 68
NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria 65
Furoxan-, alkylnitrate-derivatives and related compoundsas anti-trypanosomatid agents: Mechanism of action studies 65
PHENYLSULFONYL FUROXANS AS MODULATORS OF MULTIDRUGRESISTANCE-ASSOCIATED PROTEIN-1 AND P-GLYCOPROTEIN 63
Furoxan nitric oxide donors disperse Pseudomonas aeruginosa biofilms, accelerate growth, and repress pyoverdine production 57
Unsymmetrically Substituted Furoxans. Part 19. Methyl and Phenylfuroxansulfonic Acids and Related Sulfonamides 56
Praziquantel analogues containing NO-donor furoxans and related furazans as agents active against Schistosoma mansoni. 55
New furoxan derivatives with Schistosomicidal activity. 54
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation 53
SYNTHESIS OF AMODIAQUINE ANALOGUES WITH POTENTIAL ANTIPROTOZOAL ACTIVITY 51
Principi di Chimica Farmaceutica 48
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 38
New potent and selective P-gp inhibitors 34
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 32
Overcoming Multidrug Resistance (MDR): Design, Biological Evaluation and Molecular Modelling Studies of 2,4-Substituted Quinazoline Derivatives 7
Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers 5
Totale 5.592
Categoria #
all - tutte 14.303
article - articoli 0
book - libri 0
conference - conferenze 1.837
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020967 0 40 36 114 55 127 97 76 133 114 81 94
2020/2021696 54 52 41 38 83 45 43 55 77 61 45 102
2021/2022864 58 59 63 92 46 39 51 53 34 47 194 128
2022/2023845 106 94 25 59 75 198 82 51 77 21 34 23
2023/2024555 56 65 39 31 58 91 44 38 6 27 41 59
2024/202564 30 34 0 0 0 0 0 0 0 0 0 0
Totale 5.592